Study on the Level of Neuromuscular Blockade

Conditions

• Neuromuscular Blockade

Interventions

• DRUG: A continuous intravenous infusion of 0.5-0.6 mg/kg/h Rocuronium Bromide Intravenous Solution (50 Mg/5 mL) to keep the target neuromuscular blockade (PTC = 1-2).
• DRUG: A continuous intravenous infusion of 0.2-0.3 mg/kg/h Rocuronium Bromide Intravenous Solution (50 Mg/5 mL) to keep the target neuromuscular blockade (TOF = 1-2).

Sponsor

The First Affiliated Hospital with Nanjing Medical University

Collaborators

• [object Object]